WEGOVY 2,4 MG FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA
Analogs of WEGOVY 2,4 MG FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA
Find cheaper analogs and generic equivalents for WEGOVY 2,4 MG FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA.
Substancja czynna: semaglutide
Inactive Ingredients: FOSFATO DISODICO DIHIDRATADO HIDROGENADO 1,42 mg, HIDROXIDO DE SODIO (E 524) q.s. ml, PROPILENGLICOL 14 mg
Przegląd produktu
About WEGOVY 2,4 MG FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA
WEGOVY 2,4 MG FLEXTOUCH SOLUCION INYECTABLE EN PLUMA PRECARGADA is a prescription medication designed for subcutaneous administration. This product is supplied in a pre-filled pen delivery system, known as FlexTouch, which is engineered for ease of use during self-administration. Each pen contains a sterile solution intended for regular injection as directed by a healthcare professional. It is essential to store this medication according to the specific temperature requirements provided in the package insert to maintain its stability and efficacy. Patients should ensure they are familiar with the injection technique before the first use of the device.
Key Benefits & Uses
- Provided in a convenient, pre-filled FlexTouch injection pen.
- Designed for consistent and accurate subcutaneous dosing.
- Intended for use as part of a comprehensive weight management program.
Active Ingredient & Action
The active ingredient in this medication is semaglutide. Semaglutide functions as a glucagon-like peptide-1 receptor agonist. It works by mimicking the effects of incretin hormones in the body, which play a role in regulating appetite and caloric intake.
Important Notes
This medication must only be used under the direct supervision of a qualified medical provider. Always consult the full prescribing information for complete details regarding administration, contraindications, and safety protocols. Do not share your injection pen with others under any circumstances.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.